Decheng Capital
Decheng Capital is a global life sciences investment firm established in 2012, managing $2.1 billion in capital. The firm focuses on providing capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence. Decheng Capital aims to build highly successful companies globally, leveraging the rapid growth of the healthcare industry and breakthroughs in life science research. The firm is committed to creating value for its investors and entrepreneur partners, supported by some of the most prestigious limited partners worldwide.
Decheng Capital
3000 Sand Hill Road, Building 2, Suite 110 Menlo Park, CA 94025 Phone: (650) 233-0688 Fax: (650) 233-0988
Portfolio
#Biopharma
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Biopharma
#Biopharma
#Medical Device
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Services
#Biopharma
#Biopharma
#Biopharma
#Diagnostics and Tools
#Medical Device
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Diagnostics and Tools
#Services
#Diagnostics and Tools
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Diagnostics and Tools
#Diagnostics and Tools
#Biopharma
#Services
#Biopharma
#Biopharma
#Biopharma
#Biopharma
#Medical Device
#Diagnostics and Tools
#Biopharma
#Biopharma
#Medical Device
#Diagnostics and Tools
#Biopharma
#Biopharma
#Biopharma
#Medical Device
#Biopharma
#Medical Device
#Diagnostics and Tools
#Biopharma
#Medical Device
#Biopharma
#Medical Device
#Biopharma
#Diagnostics and Tools
#Biopharma
#Medical Device
#Biopharma
#Medical Device
#Biopharma
#Diagnostics and Tools
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Biopharma